Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



CITADEL ADVISORS LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/02/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/21/2023 SC 13G CITADEL ADVISORS LLC reports a 6.9% stake in Benitec Biopharma Inc.
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/11/2023 SC 13G CITADEL ADVISORS LLC reports a 4% stake in Expensify, Inc.
07/27/2023 SC 13G CITADEL ADVISORS LLC reports a 5.9% stake in Semper Paratus Acquisition Corporation
07/10/2023 SC 13G CITADEL ADVISORS LLC reports a 5.1% stake in Janux Therapeutics, Inc.
07/03/2023 SC 13G CITADEL ADVISORS LLC reports a 5.1% stake in Nektar Therapeutics
07/03/2023 SC 13G CITADEL ADVISORS LLC reports a 5.7% stake in Clene Inc.
06/12/2023 SC 13G CITADEL ADVISORS LLC reports a 5.9% stake in Lyra Therapeutics, Inc.
06/09/2023 SC 13G CITADEL ADVISORS LLC reports a 6% stake in Inflection Point Acquisition Corp. II
05/19/2023 SC 13G CITADEL ADVISORS LLC reports a 6.1% stake in ACELYRIN, Inc.
05/19/2023 SC 13G CITADEL ADVISORS LLC reports a 4.9% stake in PMV Pharmaceuticals, Inc.
05/19/2023 SC 13G CITADEL ADVISORS LLC reports a 5.5% stake in Alchemy Investments Acquisition Corp 1
05/19/2023 SC 13G CITADEL ADVISORS LLC reports a 6.2% stake in Coherus Biosciences, Inc.
05/15/2023 SC 13G CITADEL ADVISORS LLC reports a 6.7% stake in Magenta Therapeutics, Inc.
05/01/2023 SC 13G CITADEL ADVISORS LLC reports a 5.2% stake in 2seventy bio, Inc.
04/03/2023 SC 13G CITADEL ADVISORS LLC reports a 5.1% stake in Design Therapeutics, Inc.
03/14/2023 SC 13G CITADEL ADVISORS LLC reports a 5.4% stake in Western Alliance Bancorporation
03/06/2023 SC 13G CITADEL ADVISORS LLC reports a 5.6% stake in Enliven Therapeutics, Inc.
02/27/2023 SC 13G CITADEL ADVISORS LLC reports a 5.2% stake in Annexon, Inc.
02/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A CITADEL ADVISORS LLC reports a 4.9% stake in AltC Acquisition Corp.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A CITADEL ADVISORS LLC reports a 3.6% stake in Gores Holdings IX, Inc.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A CITADEL ADVISORS LLC reports a
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A CITADEL ADVISORS LLC reports a 7.4% stake in MoonLake Immunotherapeutics
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy